ATE342910T1 - Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält - Google Patents

Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält

Info

Publication number
ATE342910T1
ATE342910T1 AT02760637T AT02760637T ATE342910T1 AT E342910 T1 ATE342910 T1 AT E342910T1 AT 02760637 T AT02760637 T AT 02760637T AT 02760637 T AT02760637 T AT 02760637T AT E342910 T1 ATE342910 T1 AT E342910T1
Authority
AT
Austria
Prior art keywords
new
glycolipide
gen
cure
active ingredient
Prior art date
Application number
AT02760637T
Other languages
English (en)
Inventor
Takashi Yamamura
Sachiko Miyake
Original Assignee
Daiichi Asubio Pharma Co Ltd
Japan Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd, Japan Government filed Critical Daiichi Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE342910T1 publication Critical patent/ATE342910T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02760637T 2001-08-16 2002-08-14 Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält ATE342910T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001247055 2001-08-16

Publications (1)

Publication Number Publication Date
ATE342910T1 true ATE342910T1 (de) 2006-11-15

Family

ID=19076468

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760637T ATE342910T1 (de) 2001-08-16 2002-08-14 Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält

Country Status (15)

Country Link
US (1) US8367623B2 (de)
EP (1) EP1437358B1 (de)
JP (1) JP4064346B2 (de)
KR (1) KR100880063B1 (de)
CN (1) CN100439383C (de)
AT (1) ATE342910T1 (de)
AU (1) AU2002327097B2 (de)
BR (1) BR0211968A (de)
CA (1) CA2459482C (de)
DE (1) DE60215530T2 (de)
DK (1) DK1437358T3 (de)
ES (1) ES2274080T3 (de)
HU (1) HU229345B1 (de)
NO (1) NO326398B1 (de)
WO (1) WO2003016326A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
HUE037560T2 (hu) 2003-02-14 2018-09-28 Japan President Nat Ct Neurology & Psychiatry Glikolipid-származékok, eljárás elõállításukra, szintézis-köztitermékeik, és eljárás a köztitermékek elõállítására
CA2577009C (en) * 2004-08-27 2017-05-02 Steven A. Porcelli Ceramide derivatives as modulators of immunity and autoimmunity
US8513008B2 (en) 2004-10-07 2013-08-20 Argos Therapeutics, Inc. Mature dendritic cell compositions and methods for culturing same
AU2005294150B2 (en) 2004-10-07 2011-06-16 Coimmune, Inc. Mature dendritic cell compositions and methods for culturing same
US7923013B2 (en) 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
CA2591232C (en) * 2004-12-28 2014-10-21 The Rockefeller University Glycolipids and analogues thereof as antigens for nk t cells
EP1872794B1 (de) * 2005-04-01 2012-12-12 JAPAN as represented by DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES Nasale vakzine
WO2007004705A1 (ja) * 2005-07-01 2007-01-11 Japan As Represented By President Of National Center Of Neurology And Psychiatry 糖脂質誘導体及びそれを有効成分とする治療剤
WO2007049819A1 (ja) * 2005-10-28 2007-05-03 Japan As Represented By President Of National Center Of Neurology And Psychiatry Nkt細胞の機能を抑制する糖脂質誘導体を有効成分とする治療剤
JP5126684B2 (ja) * 2006-02-28 2013-01-23 独立行政法人理化学研究所 新規糖脂質及びその用途
JP5564672B2 (ja) * 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
US9603922B2 (en) 2007-02-21 2017-03-28 Vaccinex, Inc. Modulation of NKT cell activity with antigen-loaded CD1d molecules
JP5416125B2 (ja) * 2007-10-12 2014-02-12 ルイジ パンツァ， 免疫アジュバントとして有用な糖脂質の類似体
PT2385980T (pt) * 2009-01-08 2018-06-26 Albert Einstein College Medicine Inc Vacinas bacterianas com glicolípidos do tipo ceramida associados à parede celular e utilização dos mesmos
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
JP6202339B2 (ja) * 2013-12-19 2017-09-27 国立研究開発法人国立精神・神経医療研究センター ＧＭ−ＣＳＦ産生Ｔ細胞制御剤、及びＴｈ１／Ｔｈ２免疫バランス調節剤
JP6494594B2 (ja) 2014-02-26 2019-04-03 国立大学法人北海道大学 樹状細胞を含有する医薬およびその製造方法
WO2021010344A1 (ja) 2019-07-12 2021-01-21 国立大学法人九州大学 心筋収縮改善治療法および心筋細胞死抑制法の開発

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5827828A (ja) * 1981-08-11 1983-02-18 Mitsubishi Electric Corp 燃料噴射装置
DK84691D0 (da) 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
JPH0559081A (ja) * 1991-08-29 1993-03-09 Kirin Brewery Co Ltd 新規スフインゴ糖脂質、その製造法および使用
GB9207182D0 (en) * 1992-04-01 1992-05-13 Enzymatix Ltd Glycolipids and their preparation
TW261533B (de) 1992-07-16 1995-11-01 Kirin Brewery
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
DE69504134T2 (de) * 1994-05-31 1999-02-04 Seikagaku Kogyo Co Ltd Glycolipidanalogen als Glukosidaseinhibitoren
DE19602108A1 (de) 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
JP4451933B2 (ja) * 1996-12-27 2010-04-14 住友化学株式会社 遺伝子操作による植物へのｐｐｏ阻害性除草剤耐性付与法
CA2286482C (en) * 1997-04-10 2008-08-05 Kirin Beer Kabushiki Kaisha Nkt cell-activating agents containing .alpha.-glycosylceramides
US6589940B1 (en) * 1997-06-06 2003-07-08 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
US7273711B1 (en) * 1998-12-02 2007-09-25 The Regents Of The University Of California Diagnosis of human glycosylation disorders
JP2002284692A (ja) * 2001-03-26 2002-10-03 Kirin Brewery Co Ltd α−グリコシルセラミドによる移植片対宿主病（ＧＶＨＤ）の抑制

Also Published As

Publication number Publication date
EP1437358A4 (de) 2004-11-24
US20060148723A1 (en) 2006-07-06
CN100439383C (zh) 2008-12-03
HUP0500127A3 (en) 2009-12-28
ES2274080T3 (es) 2007-05-16
JPWO2003016326A1 (ja) 2004-12-02
BR0211968A (pt) 2004-09-28
HUP0500127A2 (en) 2006-09-28
EP1437358B1 (de) 2006-10-18
CA2459482A1 (en) 2003-02-27
US8367623B2 (en) 2013-02-05
KR20040039287A (ko) 2004-05-10
NO326398B1 (no) 2008-11-24
NO20040653L (no) 2004-05-07
JP4064346B2 (ja) 2008-03-19
KR100880063B1 (ko) 2009-01-22
DE60215530T2 (de) 2007-05-31
DK1437358T3 (da) 2007-02-05
AU2002327097B2 (en) 2007-05-24
DE60215530D1 (de) 2006-11-30
CN1568328A (zh) 2005-01-19
HU229345B1 (en) 2013-11-28
EP1437358A1 (de) 2004-07-14
WO2003016326A1 (fr) 2003-02-27
CA2459482C (en) 2010-09-28

Similar Documents

Publication Publication Date Title
ATE342910T1 (de) Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält
CA2678795C (en) Antibacterial cyclohexylsulfanyl pleuromutilins
DE69129193D1 (en) Triterpenderivat
DE69634678D1 (de) Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen
UA94913C2 (ru) Применение эритропоэтина для лечения сахарного диабета
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
MY106596A (en) Antifungal agents based on amides containing a phenyl group
NO307461B1 (no) Substituerte bifenyl-isoksazol-sulfonamider, anvendelse derav og farmasøytisk preparat
HK1029526A1 (en) Nkt cell-activating agents containing alpha-glycosylceramides
EP1836180A2 (de) Sulfonylpyrrolidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ504023A (en) Aminotriazole compounds, their preparation and pharmaceutical compositions
ATE541854T1 (de) Pyrazolderivat, arzneimittelzusammensetzung, die dieses enthält, und zwischenprodukt für dessen herstellung
HUT72653A (en) N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) and pharmaceutical compositions of hypercholesterolemic activity containing them
IL178350A0 (en) Vitamin d derivatives
GT200000025A (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos.
AU2008207170A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
ZA878212B (en) Sulfone peroxycarboxylic acids
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
NZ320580A (en) Tricyclic compounds, preparation and pharmaceutical compositions thereof
ATE290526T1 (de) Vitamin-d3?-derivate und aus diesen hergestellte heilmittel gegen entzündliche erkrankungen der atemwege
TR199902350T2 (xx) Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler.
ES8400135A1 (es) "un procedimiento para la obtencion de polimeros de tres componentes portadores de grupos carboxilicos".
TW200502695A (en) Basic compound, resist composition and patterning process
HUT54372A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
NO157297C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-acylthio-15,16-methylen-3-oxo-17alfa-pregna-1,4-dien-21,17-carbolactoner.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties